Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Long-acting co-agonists of the glucagon and GLP-1 receptors

Long-acting co-agonists of the glucagon and GLP-1 receptors

US Patent 11492385 · Granted Nov 8, 2022

Estimated economic value: $310,648,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine recept2025
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine recept2025
Macrocyclic peptides as potent inhibitors of K-RAS G12D mutant2025
Small molecule inhibitors of KRAS G12C mutant2025
Small molecule inhibitors of KRAS G12C mutant2025
7-, 8-, and 10-substituted amino triazolo quinazoline derivatives as adenosine r2025
Arginase inhibitors and methods of use2025
Arginase inhibitors and methods of use2025
PCSK9 antagonist compounds2025
9-substituted amino triazolo quinazoline derivatives as adenosine receptor antag2024
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammator2024
Cyclic polypeptides for PCSK9 inhibition2024